TBBC yields 32.15% · ABBV yields 3.06%● Live data
📍 TBBC pulled ahead of the other in Year 1
Combined, TBBC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TBBC + ABBV for your $10,000?
Triad Business Bank provides various banking products and services in the United States. It offers checking, savings, money market, and retirement accounts, as well as certificates of deposit; and home equity loan, real estate investment purchases or refinances, and refinance existing loan services, as well as acquisition financing and working capital loans. The company also provides online banking, personal online bill pay, E-statements, personal debit cards, and mobile deposit and banking services, as well as treasury solutions and merchant services. In addition, the company offers letters of credit products, such as export letters of credit, export documentary collections, import letter of credit, import documentary collections, and foreign or domestic letters of credit; and lines of credit products, including revolving, equipment purchases, guidance, seasonal cash flow, additional working capital, and inventory financing. Further, the company provides lockbox, remote deposit capture, and mobile capture services; ACH origination, wire origination, and purchase card services; and fraud protection services. Additionally, it offers zero balance, line of credit, and checking sweep services. The company operates three banking offices in the Triad region of North Carolina. Triad Business Bank was incorporated in 2020 and is based in Greensboro, North Carolina.
Full TBBC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.